Denning G M, Ostedgaard L S, Welsh M J
Howard Hughes Medical Institute, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.
J Cell Biol. 1992 Aug;118(3):551-9. doi: 10.1083/jcb.118.3.551.
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a membrane glycoprotein that forms Cl- channels. Previous work has shown that when some CF-associated mutants of CFTR are expressed in heterologous cells, their glycosylation is incomplete. That observation led to the hypothesis that such mutants are not delivered to the plasma membrane where they can mediate Cl- transport. Testing this hypothesis requires localization of CFTR in nonrecombinant cells and a specific determination of whether CFTR is in the apical membrane of normal and CF epithelia. To test the hypothesis, we used primary cultures of airway epithelia grown on permeable supports because they polarize and express the CF defect in apical Cl- permeability. Moreover, their dysfunction contributes to disease. We developed a semiquantitative assay, using nonpermeabilized epithelia, an antibody directed against an extracellular epitope of CFTR, and large (1 microns) fluorescent beads which bound to secondary antibodies. We observed specific binding to airway epithelia from non-CF subjects, indicating that CFTR is located in the apical membrane. In contrast, there was no specific binding to the apical membrane of CF airway epithelia. These data were supported by qualitative studies using confocal microscopy: the most prominent immunostaining was in the apical region of non-CF cells and in cytoplasmic regions of CF cells. The results indicate that CFTR is either missing from the apical membrane of these CF cells or it is present at a much reduced level. The data support the proposed defective delivery of some CF-associated mutants to the plasma membrane and explain the lack of apical Cl- permeability in most CF airway epithelia.
囊性纤维化(CF)是由囊性纤维化跨膜传导调节因子(CFTR)的突变引起的,CFTR是一种形成氯离子通道的膜糖蛋白。先前的研究表明,当一些与CF相关的CFTR突变体在异源细胞中表达时,它们的糖基化是不完全的。这一观察结果导致了这样一种假设,即这些突变体没有被运送到质膜,而在质膜上它们可以介导氯离子运输。要验证这一假设,需要在非重组细胞中定位CFTR,并具体确定CFTR是否存在于正常和CF上皮细胞的顶端膜中。为了验证这一假设,我们使用了在可渗透支持物上生长的气道上皮细胞原代培养物,因为它们会极化并在顶端氯离子通透性方面表现出CF缺陷。此外,它们的功能障碍会导致疾病。我们开发了一种半定量检测方法,使用非通透化的上皮细胞、一种针对CFTR细胞外表位的抗体以及与二抗结合的大(1微米)荧光珠。我们观察到来自非CF受试者的气道上皮细胞有特异性结合,表明CFTR位于顶端膜中。相比之下,CF气道上皮细胞的顶端膜没有特异性结合。这些数据得到了使用共聚焦显微镜的定性研究的支持:最显著的免疫染色出现在非CF细胞的顶端区域和CF细胞的细胞质区域。结果表明,这些CF细胞的顶端膜中要么没有CFTR,要么其含量大大降低。这些数据支持了一些与CF相关的突变体向质膜转运存在缺陷的假设,并解释了大多数CF气道上皮细胞缺乏顶端氯离子通透性的原因。